BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25046458)

  • 1. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
    Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
    Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous ulceration as a sign of methotrexate toxicity.
    Del Pozo J; Martínez W; García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
    Eur J Dermatol; 2001; 11(5):450-2. PubMed ID: 11525955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature.
    Kurian A; Haber R
    J Cutan Med Surg; 2011; 15(5):275-9. PubMed ID: 21962187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
    Ferguson NN; Asarch A; VanBeek M; Swick BL
    Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
    Klemencic S
    Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
    Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
    Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
    Lim AY; Gaffney K; Scott DG
    Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucocutaneous ulcerations secondary to methotrexate.
    Warner J; Brown A; Whitmore SE; Cowan DA
    Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Pancytopenia Following Single Dose Methotrexate In Psoriasis: A Rare And Potentially Lethal Manifestation.
    Singh A; Choudhary R; Chhabra N; Ganguly S; Rathore V
    Curr Drug Saf; 2021; 16(1):110-113. PubMed ID: 33106147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques.
    Koçak AY; Koçak O; Aslan F; Tektaş M
    Cutan Ocul Toxicol; 2013 Oct; 32(4):333-5. PubMed ID: 23537374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
    Delyon J; Ortonne N; Benayoun E; Moroch J; Wolkenstein P; Sbidian E; Chosidow O
    J Am Acad Dermatol; 2015 Sep; 73(3):484-90. PubMed ID: 26190242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and doxycycline interaction: a rare cause of pancytopenia.
    Arslan A; Zain MA; Mukhtar M; Ullah W; Roomi S
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-Induced Cutaneous Erosions.
    Mönch S; Zimmo B; El Helou T; Colmegna I
    Arthritis Rheumatol; 2016 Jan; 68(1):254. PubMed ID: 26314707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.